Cargando…
Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors
Glioblastoma (GBM) is the leading malignant intracranial tumor and is associated with a poor prognosis. Highly purified, activated natural killer (NK) cells, designated as genuine induced NK cells (GiNKs), represent a promising immunotherapy for GBM. We evaluated the anti-tumor effect of GiNKs in as...
Autores principales: | Shida, Yoichi, Nakazawa, Tsutomu, Matsuda, Ryosuke, Morimoto, Takayuki, Nishimura, Fumihiko, Nakamura, Mitsutoshi, Maeoka, Ryosuke, Yamada, Shuichi, Nakagawa, Ichiro, Park, Young-Soo, Yasukawa, Motoaki, Tojo, Takashi, Tsujimura, Takahiro, Nakase, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472834/ https://www.ncbi.nlm.nih.gov/pubmed/34576141 http://dx.doi.org/10.3390/ijms22189975 |
Ejemplares similares
-
Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors
por: Nakazawa, Tsutomu, et al.
Publicado: (2022) -
Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom
por: Maeoka, Ryosuke, et al.
Publicado: (2023) -
An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood
por: Nakazawa, Tsutomu, et al.
Publicado: (2023) -
CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
por: Nakazawa, Tsutomu, et al.
Publicado: (2023) -
Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023)